Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial | |
Wei, Lai; Xie, Qing; Huang, Yan; Wu, Shanming; Xu, Min; Tang, Hong; Cheng, Jun; Gao, Yanhang; Mou, Zhuangbo; Dou, Xiaoguang | |
2018 | |
会议名称 | Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting |
会议日期 | NOV 09-13, 2018 |
卷号 | 68 |
页码 | 379A-379A |
收录类别 | CPCI-S ; SCIE |
会议录 | HEPATOLOGY |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6027114 |
专题 | 山东大学 |
作者单位 | 1.Peking Univ, Peoples Hosp, Inst Hepatol, Beijing, Peoples R China. 2.Ruijin Hosp, Shanghai, Peoples R China. 3.C |
推荐引用方式 GB/T 7714 | Wei, Lai,Xie, Qing,Huang, Yan,et al. Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial[C]. 见:Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting. NOV 09-13, 2018. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论